Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients

FOLFIRINOX is superior to gemcitabine in patients with pancreatic cancer, but this regimen is associated with toxicity and biomarkers for response are warranted. MicroRNAs can mediate drug resistance and could provide predictive information. Altered expressions of several microRNAs including miR-21-...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Future Sci OA
Κύριοι συγγραφείς: Schlick, Konstantin, Hohla, Florian, Hamacher, Frank, Hackl, Hubert, Hufnagl, Clemens, Markus, Steiner, Magnes, Teresa, Gampenrieder, Simon Peter, Melchardt, Thomas, Stättner, Stefan, Hauser-Kronberger, Cornelia, Greil, Richard, Rinnerthaler, Gabriel
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Future Science Ltd 2020
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7787156/
https://ncbi.nlm.nih.gov/pubmed/33437513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2144/fsoa-2020-0128
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια